XML 23 R9.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Cash flows from operating activities:      
Net income $ 21,462 $ 63,903 $ 55,924
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 14,164 14,592 14,309
Bad debt expense 310 554 173
Share-based compensation expenses 1,818 1,929 1,840
Loss (gain) on disposals of property and equipment (2) (2) 88
Gain on disposals of equity method investment (88) 0 (54)
Gain on disposals of investment securities, net (1,682) (10,502) 0
Loss (gain) on disposals of marketable securities, net (223) 31 8
Impairment loss on investment 0 309 0
Equity in losses of equity method investees 77 80 122
Valuation gain on financial instruments 0 (1,255) (160)
Issuance of new shares by subsidiary for royalties 0 0 49
Deferred income tax expense 4,148 3,816 7,409
Inventories write downs 9,785 8,198 10,759
Changes in:      
Accounts receivable 41,656 (19,211) (65,106)
Accounts receivable from related parties 0 0 73,267
Inventories (15,054) 3,096 (71,488)
Prepaid expenses and other current assets 2,067 1,053 (1,857)
Accounts payable (54,905) 28,038 15,744
Income taxes payable (6,475) 2,357 7,055
Other accrued expenses and other current liabilities 5,987 (3,262) 2,812
Other liabilities (516) (5) 229
Net cash provided by operating activities 22,529 93,719 51,123
Cash flows from investing activities:      
Purchases of property, plant and equipment (9,982) (10,931) (18,412)
Proceeds from disposals of property and equipment 8 1 0
Purchases of available-for-sale marketable securities (63,051) (23,766) (22,410)
Proceeds from disposals of available-for-sale marketable securities 46,720 22,021 21,792
Purchases of investment securities 0 0 (9,189)
Proceeds from disposals of investment securities 1,682 19,691 0
Proceeds from capital reduction of investment 0 1,168 0
Purchase of equity method investment (3,708) 0 0
Proceeds from disposals of equity method investment 179 0 0
Repayments of refundable deposits, net (304) (237) (541)
Releases (pledges) of restricted cash, cash equivalents and marketable securities (227) 2,697 (1,761)
Cash received from the acquisition of Liqxtal, net of cash paid of $1,780 341 0 0
Cash increase (decrease) resulting from change in consolidated entity 0 0 (4)
Net cash provided by (used in) investing activities (28,342) 10,644 (30,525)
Cash flows from financing activities:      
Payments of cash dividends (51,364) (46,042) (42,394)
Excess tax benefits from share-based compensation 771 1,232 1,271
Proceeds from disposals of subsidiary shares to noncontrolling interests by Himax Technologies Limited 0 83 0
Proceeds from disposals of subsidiary shares to noncontrolling interests by Himax Imaging, Inc. 22 38 64
Purchases of subsidiary shares from noncontrolling interests (503) (1,515) (896)
Pledges of restricted cash, cash equivalents and marketable securities (for borrowing of short-term debt) (50,000) (24,500) (32,500)
Proceeds from issuances of new shares by subsidiaries 1,466 0 9,852
Proceeds from short-term debt 412,303 417,500 352,320
Repayments of short-term debt (362,303) (393,000) (319,820)
Net cash used in financing activities (49,608) (46,204) (32,103)
Effect of foreign currency exchange rate changes on cash and cash equivalents (216) (13) 88
Net increase (decrease) in cash and cash equivalents (55,637) 58,146 (11,417)
Cash and cash equivalents at beginning of year 185,466 127,320 138,737
Cash and cash equivalents at end of year 129,829 185,466 127,320
Supplemental disclosures of cash flow information:      
Interest 516 592 401
Income taxes 12,505 13,311 3,272
Supplemental disclosures of investing activities affecting both cash and non-cash items:      
Purchase of property, plant and equipment 10,567 10,385 19,607
Decrease (increase) in payable for purchases of equipment and asset retirement obligations (585) 546 (1,195)
Cash paid $ 9,982 $ 10,931 $ 18,412